Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2343 ARTíCULOS , VIENDO DEL 136 AL 150

PUBMED

Evaluation of the turning characteristics according to the severity of Parkinson disease during the timed up and go test.

Son M, Youm C, Cheon S, Kim J, Lee M, Kim Y, Kim J, Sung H.

Aging Clin Exp Res. 2017 Feb 20. doi: 10.1007/s40520-016-0719-y. [Epub ahead of print]

0

0

0

PUBMED

Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.

Yuan X, Cao B, Wu Y, Chen Y, Wei Q, Ou R, Yang J, Chen X, Zhao B, Song W, Shang H.

Neurosci Lett. 2017 Nov 8;664:128-132. doi: 10.1016/j.neulet.2017.11.015. [Epub ahead of print]

0

0

0

PUBMED

Promising rodent models in Parkinson's disease.

Imbriani P, Sciamanna G, Santoro M, Schirinzi T, Pisani A.

Parkinsonism Relat Disord. 2017 Jul 27. pii: S1353-8020(17)30274-2. doi: 10.1016/j.parkreldis.2017.07.027. [Epub ahead of print]

0

0

0

PUBMED

Cerebellar Volume and Executive Function in Parkinson Disease with and Without Freezing of Gait.

Myers PS, McNeely ME, Koller JM, Earhart GM, Campbell MC.

J Parkinsons Dis. 2017 Jan 17. doi: 10.3233/JPD-161029. [Epub ahead of print]

0

0

0

PUBMED

Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.

Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Hattori M, Kawabata K, Hara K, Ito M, Fujimoto Y, Nakatsubo D, Maesawa S, Kajita Y, Katsuno M, Sobue G.

J Neural Transm (Vienna). 2017 Dec;124(12):1547-1556. doi: 10.1007/s00702-017-1804-x. Epub 2017 Nov 2.

0

0

0

PUBMED

Inhibitory control is not lateralized in Parkinson's patients.

Mirabella G, Fragola M, Giannini G, Modugno N, Lakens D.

Neuropsychologia. 2017 Jun 22;102:177-189. doi: 10.1016/j.neuropsychologia.2017.06.025. [Epub ahead of print]

0

0

0

PUBMED

Association of soil selenium, strontium, and magnesium concentrations with Parkinson's disease mortality rates in the USA.

Sun H.

Environ Geochem Health. 2017 Feb 7. doi: 10.1007/s10653-017-9915-8. [Epub ahead of print]

0

0

0

PUBMED

In-hospital Complications Following Lumbar Spine Surgery in Patients with Parkinson's Disease: Evaluation of the National Inpatient Sample Database.

Baker JF, McClelland S 3rd, Line BG, Smith JS, Hart RA, Ames CP, Shaffrey C, Bess S.

World Neurosurg. 2017 Jul 12. pii: S1878-8750(17)31105-1. doi: 10.1016/j.wneu.2017.07.006. [Epub ahead of print]

0

0

0

PUBMED

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.

Niu S, Zhang LK, Zhang L, Zhuang S, Zhan X, Chen WY, Du S, Yin L, You R, Li CH, Guan YQ.

Theranostics. 2017 Jan 1;7(2):344-356. doi: 10.7150/thno.16562.

0

0

0

PUBMED

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS.

Mov Disord. 2017 Nov 23. doi: 10.1002/mds.27204. [Epub ahead of print]

0

0

0

PUBMED

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.

Farotti L, Paciotti S, Tasegian A, Eusebi P, Parnetti L.

Expert Rev Mol Diagn. 2017 Jun 19:1-10. doi: 10.1080/14737159.2017.1341312. [Epub ahead of print]

0

0

0

PUBMED

The Level of Knowledge of Parkinson's Disease among Nonprofessional Caregivers in a Movement Disorders Center in Turkey.

Gultekin M, Sarılar AC, Ekinci A, Erturk G, Mirza M.

Parkinsons Dis. 2017;2017:2652361. doi: 10.1155/2017/2652361. Epub 2017 Mar 1.

0

0

0

PUBMED

Nature's Parkin experiment: Nix-a novel protective mechanism in Parkinson's disease.

Olszewska DA, Lynch T.

Mov Disord. 2017 Jul;32(7):992. doi: 10.1002/mds.27015. Epub 2017 Apr 22. No abstract available.

0

0

0

PUBMED

Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.

Mori MA, Delattre AM, Carabelli B, Pudell C, Bortolanza M, Staziaki PV, Visentainer JV, Montanher PF, Del Bel EA, Ferraz AC.

Nutr Neurosci. 2017 Feb 21:1-11. doi: 10.1080/1028415X.2017.1290928. [Epub ahead of print]

0

0

0

PUBMED

Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline.

Ayala A, Triviño-Juárez JM, Forjaz MJ, Rodríguez-Blázquez C, Rojo-Abuin JM, Martínez-Martín P.

Front Neurol. 2017 Oct 30;8:551. doi: 10.3389/fneur.2017.00551. eCollection 2017.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy